Evidence map›Paper›PMID 23447598›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms.

Yan Yan, Xiaofeng Zhou, Zui Pan, Jianjie Ma, James A Waschek, Emanuel DiCicco-Bloom

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.Journal of molecular neuroscience : MN · 2017
    Article
  11. PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.Journal of molecular neuroscience : MN · 2016
    Article
  12. Article
  13. Article
  14. Zac1 Regulates the Differentiation and Migration of Neocortical Neurons via Pac1.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Yan YanDepartment of Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
Xiaofeng Zhou
Zui Pan
Jianjie Ma
James A Waschek
Emanuel DiCicco-Bloom
Institute of Molecular Biology and Biophysics · RUJohnson University · USRutgers, The State University of New Jersey · USUniversity of California, Los Angeles · US

Funding

Stem CellsP30HD004612 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CARPENTER, ELLEN M. · 1985 to 2014
$19.5M
VIP AND PACP ACTION IN CNS DEVELOPMENT AND INJURYP01HD006576 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DE VELLIS, JEAN · 1985 to 2006
$7.8M
Modulation of MG53 Function in Cardiac Membrane RepairR01HL069000 · NHLBI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MA, JIANJIE · 2002 to 2016
$5.3M
Ca Sparks in Muscle Aging and DystrophyR01AG028614 · NIA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MA, JIANJIE · 2006 to 2016
$4.1M
PACAP REGULATION OF NEUROGENESIS AND SURVIVALR01NS032401 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI DICICCO-BLOOM, EMANUEL MURRAY · 1994 to 2009
$2.0M
REGULATION OF NEURAL PRECURSORS: ROLE OF NEUROPEPTIDESR01HD034475 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASCHEK, JAMES A · 1997 to 2006
$1.6M
NHLBI NIH HHS HL069000NHLBI NIH HHS R01 HL069000NIA NIH HHS AG028614NIA NIH HHS R01 AG028614NICHD NIH HHS HD04612NICHD NIH HHS HD06576NICHD NIH HHS HD34475NICHD NIH HHS P01 HD006576NICHD NIH HHS P30 HD004612NICHD NIH HHS R01 HD034475NINDS NIH HHS NS32401NINDS NIH HHS R01 NS032401
6 · The paper itself

Abstract

During corticogenesis, pituitary adenylate cyclase-activating polypeptide (PACAP; ADCYAP1) may contribute to proliferation control by activating PAC1 receptors of neural precursors in the embryonic ventricular zone. PAC1 receptors, specifically the hop and short isoforms, couple differentially to and activate distinct pathways that produce pro- or anti-mitogenic actions. Previously, we found that PACAP was an anti-mitogenic signal from embryonic day 13.5 (E13.5) onward both in culture and in vivo and activated cAMP signaling through the short isoform. However, we now find that mice deficient in PACAP exhibited a decrease in the BrdU labeling index (LI) in E9.5 cortex, suggesting that PACAP normally promotes proliferation at this stage. To further define mechanisms, we established a novel culture model in which the viability of very early cortical precursors (E9.5 mouse and E10.5 rat) could be maintained. At this stage, we found that PACAP evoked intracellular calcium fluxes and increased phospho-PKC levels, as well as stimulated G1 cyclin mRNAs and proteins, S-phase entry, and proliferation without affecting cell survival. Significantly, expression of hop receptor isoform was 24-fold greater than the short isoform at E10.5, a ratio that was reversed at E14.5 when short expression was 15-fold greater and PACAP inhibited mitogenesis. Enhanced hop isoform expression, elicited by in vitro treatment of E10.5 precursors with retinoic acid, correlated with sustained pro-mitogenic action of PACAP beyond the developmental switch. Conversely, depletion of hop receptor using short-hairpin RNA abolished PACAP mitogenic stimulation at E10.5. These observations suggest that PACAP elicits temporally specific effects on cortical proliferation via developmentally regulated expression of specific receptor isoforms.

Indexed as

Age FactorsAnimalsBromodeoxyuridineCalciumCell CycleCell DivisionCell ProliferationCells, CulturedCell SurvivalCerebral CortexCerebral VentriclesDose-Response Relationship, DrugEmbryo, MammalianEnzyme InhibitorsEstrenesFemale1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dioneBromodeoxyuridineCalciumEnzyme InhibitorsEstrenesMitogensNerve Tissue ProteinsPituitary Adenylate Cyclase-Activating PolypeptideProtein Kinase CPyridinesPyrrolidinonesReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IRNA IsoformsRNA, Small InterferingTretinointris(2-pyridylmethyl)amine

Identifiers

PMID23447598
PMCPMC3652328
OpenAlexW2049828621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.